Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A112H2 | ISIN: US1488061029 | Ticker-Symbol: N/A
Frankfurt
17.12.24 | 08:00
59,93 Euro
0,00 % 0,00
1-Jahres-Chart  (nicht börsennotiert)
CATALENT INC Chart 1 Jahr

Aktuelle News zur CATALENT

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.05.Prolific Machines Appoints Former Catalent Chief Scientific Officer to Board of Directors248Expert appointment further accelerates Prolific's ability to deliver impactful protein production solutions as it prepares to expand its light-controlled bioproduction offerings Prolific Machines...
► Artikel lesen
23.04.Silexion Therapeutics Stock Surges 52% On Catalent Collaboration For Cancer Therapy1
23.04.Silexion Therapeutics Corp: Silexion Therapeutics Announces Collaboration with Global Therapeutics Leader Catalent on Advanced siRNA Formulation Development & Clinical Manufacturing Activities7
15.04.Lisata Therapeutics announces research license with Catalent1
04.02.Ardena Acquires Catalent's Drug Product Manufacturing Facility in Somerset, NJ3
04.02.Ardena Holding NV.: Ardena Completes Acquisition of Advanced Drug Product Manufacturing Facility from Catalent and Expands Bioanalytical Services in North America419Ghent, Belgium, 4th February 2025 Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO) and bioanalytical Contract Research Organization (CRO) with facilities...
► Artikel lesen
CATALENT Aktie jetzt für 0€ handeln
03.02.Jupiter Neurosciences Partners with Catalent to Produce JOTROL Softgels for Upcoming Clinical Trial4
23.01.Galapagos inks agreement with Catalent for experimental CAR-T therapy26
23.01.Pharmaceutical Technology Excellence Awards 2024: Catalent2
22.01.Catalent backs decentralised manufacture of Galapagos' CAR-T therapy20
21.01.Catalent to Support Galapagos' Decentralized CAR-T Therapy Trials4
16.01.Novo Holdings looks to double Catalent size with eye on Trump US manufacturing focus4
30.12.24Catalent, Inc. - 15-12G, Securities registration termination4
19.12.24Novo completes $16.5bn takeover of Catalent55
19.12.24Novo Holdings completes Catalent acquisition for $16.5bn2
19.12.24Lennox To Join S&P 500 Index, Replacing Catalent3
19.12.24Lennox International to join S&P 500 before the end of 2024, replacing Catalent2
18.12.24XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 18.12.20241.034The following instruments on Boerse Frankfurt do have their last trading day on 18.12.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 18.12.2024ISIN NameJP3802670004 FANCL...
► Artikel lesen
18.12.24Novo Holdings Completes Acquisition of Catalent2
18.12.24Novo Holdings Acquires Catalent In $16.5 Bln Cash Deal557WASHINGTON (dpa-AFX) - Wednesday, Novo Holdings A/S completed the acquisition of Catalent, Inc. (CTLT), a global contract development and manufacturing organization, in an all-cash transaction...
► Artikel lesen
Weiter >>
67 Nachrichten in den letzten 12 Monaten